|
|
|
|
| LEADER |
00000cam a2200000 i 4500 |
| 001 |
SCIDIR_on1285240324 |
| 003 |
OCoLC |
| 005 |
20231120010615.0 |
| 006 |
m o d |
| 007 |
cr |n||||||||| |
| 008 |
211114s2022 enk ob 001 0 eng d |
| 040 |
|
|
|a YDX
|b eng
|e rda
|e pn
|c YDX
|d GZM
|d OPELS
|d OCLCF
|d OCLCO
|d N$T
|d OCLCQ
|d SFB
|d OCLCO
|d K6U
|d OCLCQ
|
| 019 |
|
|
|a 1285253388
|a 1285272822
|
| 020 |
|
|
|a 9780323858090
|q (electronic bk.)
|
| 020 |
|
|
|a 0323858090
|q (electronic bk.)
|
| 020 |
|
|
|z 9780323858441
|
| 020 |
|
|
|z 0323858449
|
| 035 |
|
|
|a (OCoLC)1285240324
|z (OCoLC)1285253388
|z (OCoLC)1285272822
|
| 050 |
|
4 |
|a RA652
|
| 082 |
0 |
4 |
|a 614.4
|2 23
|
| 245 |
0 |
0 |
|a COVID-19 :
|b tackling global pandemics through scientific and social tools /
|c edited by Saptarshi Chatterjee.
|
| 264 |
|
1 |
|a London :
|b Academic Press,
|c [2022]
|
| 300 |
|
|
|a 1 online resource
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 505 |
0 |
|
|a Front Cover -- COVID-19: Tackling Global Pandemics through Scientific and Social Tools -- COVID-19: Tackling Global Pandemics through Scientific and Social Tools -- Copyright -- Contributors -- Contents -- 1 -- Application of CRISPR-Based Diagnostic Tools in Detecting SARS-CoV-2 Infection -- 1. INTRODUCTION -- 2. CURRENT STATUS OF WIDELY APPLIED DIAGNOSTIC METHODS FOR DETECTING SARS-COV-2 INFECTION -- 2.1 Quantitative Reverse Transcription-Polymerase Chain Reaction-Based Detection -- 2.2 LAMP/RT-LAMP-Based Detection -- 2.3 Serologic Immune Assay-Based Detection -- 2.4 Imaging-Based Detection and Confirmation -- 3. CRISPR-CAS SYSTEM AS A DIAGNOSTIC TOOL IN INFECTIOUS DISEASES -- 3.1 CRISPR-Cas Systems -- 3.1.1 Type II: CRISPR-Cas9 system -- 3.1.2 Type V: CRISPR-Cas12 system -- 3.1.3 Type VI: CRISPR-Cas13 system -- 3.2 Application of the CRISPR-Cas System in Infectious Diseases Before the Emergence of SARS-CoV-2 -- 3.3 Application of the CRISPR-Cas System in SARS-CoV-2 Detection -- 4. CONCLUDING REMARKS AND FUTURE PERSPECTIVES -- REFERENCES -- 2 -- COVID-19 Pandemic: Animal Cross Talk and Comparison Between nSARS-CoV-2 and Animal Coronaviruses -- 1. INTRODUCTION -- 2. CORONAVIRUSES: TAXONOMY, CLASSIFICATION, AND STRUCTURES -- 3. TRANSMISSION OF CORONAVIRUSES -- 4. ANIMAL CORONAVIRUSES -- 4.1 Coronaviruses in Ruminants -- 4.2 Coronaviruses in Companion Animals -- 4.3 Coronaviruses in Laboratory and Wild Animals -- 4.4 Coronaviruses of Poultry and Other Birds -- 5. NSARS-COV-2 AND OTHER HUMAN CORONAVIRUSES -- 6. RELATIONSHIP BETWEEN SARS-COV-2 AND ANIMAL CORONAVIRUSES -- 7. ORIGIN, ANIMAL LINKS OF NSARS-COV-2, AND CONTROVERSY REGARDING ZOONOSES -- 8. CONCLUSION -- REFERENCES -- 3 -- Vaccine Development Through Reverse Vaccinology Using Artificial Intelligence and Machine Learning Approach -- 1. INTRODUCTION.
|
| 505 |
8 |
|
|a 2. FROM TRADITIONAL VACCINOLOGY TO REVERSE VACCINOLOGY -- 3. ARTIFICIAL INTELLIGENCE-BASED ALGORITHMS IN REVERSE VACCINOLOGY -- 4. IMMUNOINFORMATICS TOOLS USING ARTIFICIAL INTELLIGENCE-BASED ALGORITHMS AND CLASSIFIERS -- 4.1 B-Cell Epitope Prediction -- 4.2 Major Histocompatibility Complex-Binding Peptide and T-Cell Epitope Prediction -- 4.3 Allergen Prediction Tools -- 4.4 Tools for In Silico Vaccination -- 4.5 Commercial Software and Tools -- 5. IMPLEMENTING REVERSE VACCINOLOGY IN VACCINE DEVELOPMENT ENDEAVORS -- 6. CONCLUSION -- REFERENCES -- 4 -- Riddle of Herd Immunity in SARS-CoV-2-Induced Viral Terrorism: Science to Society -- 1. HERD IMMUNITY -- 2. NETWORK AMONG THE MICROBIOME, NUTRIENTS, AND ENVIRONMENTAL FACTORS INFLUENCES IMMUNE SYSTEM DEVELOPMENT -- 2.1 Impact of Microbiome-The Second Brain to Mature the Immune System -- 2.2 Effect of Nutrients -- 2.3 Environmental Factors, Microbiome, and Vaccine Efficacy -- 3. VACCINE CANDIDATE AND ROUTE OF IMMUNIZATION DETERMINE THE FATE OF HERD IMMUNITY -- 4. POTENTIAL ENGROSSMENT OF THE MICROBIOME FROM INDIVIDUAL VACCINATION TO COMMUNITY IMMUNITY -- 4.1 Variable Expression of Microbiota Defines the Outcome of Vaccination -- 4.2 Exacerbation of the Vaccination Process Because of Environmental Enteropathy -- 4.3 Counterintuition Between Probiotics and Antibiotics on the Efficacy of Vaccination -- 5. INNATE IMMUNITY SETS THE FOOTPRINTS FOR ANTIBODY TITER -- 6. INNATE IMMUNITY: FUNDAMENTAL FACTOR FOR SPECIFICITY OF HERD IMMUNITY -- 7. MONARCHY OF SOCIETY IMMUNITY CAN BE FOUNDED BY HETEROLOGOUS IMMUNITY -- 8. THE PREVALENCE OF HETEROLOGOUS IMMUNITY CORRELATES WELL WITH LOW SARS-COV-2 INFECTION RATE IN INDIA -- 8.1 Influence of Microbiota on Community Immunity in Coronavirus Infection -- 8.2 Microbiome: Novel Song in an Old Melody -- 8.3 Herd Immunity: Friends or Foes for COVID-19.
|
| 505 |
8 |
|
|a 8.4 Poliovirus Vaccine May Provide Heterologous Protection Against COVID-19 -- 8.5 In silico Comparison of SARS-CoV-2 With OPV and BCG -- 9. PERSPECTIVES AND FUTURE OPPORTUNITIES -- 10. CONCLUSIONS -- REFERENCES -- 5 -- Tackling COVID-19 Using Small-Molecule Drugs -- 1. REMDESIVIR -- 2. HYDROXYCHLOROQUINE AND CHLOROQUINE -- 3. FAVIPIRAVIR -- 4. GALIDESIVIR -- 5. RIBAVIRIN -- 6. PIRFENIDONE -- 7. NINTEDANIB -- 8. DEXAMETHASONE -- 9. BARICITINIB AND RUXOLITINIB -- 10. CHLORPROMAZINE -- 11. CAMOSTAT MESYLATE -- 12. BROMHEXINE -- 13. LOPINAVIR/RITONAVIR -- 14. FAMOTIDINE -- 15. OSELTAMIVIR -- 16. NICLOSAMIDE -- 17. NITAZOXANIDE -- 18. UMIFENOVIR -- 19. IVERMECTIN -- 20. SELINEXOR -- 21. SIROLIMUS (RAPAMYCIN) -- 22. VALSARTAN -- 23. CAPTOPRIL -- REFERENCES -- 6 -- Modeling of COVID-19 Outbreak in Reference to Physical Parameters -- 1. INTRODUCTION -- 2. MATERIALS AND METHODS -- 3. RESULTS AND DISCUSSION -- 3.1 Modeling on the Confirmed Cases About the Maximum Temperature -- 3.2 Modeling on the Confirmed Cases About the Minimum Temperature -- 3.3 Modeling on the Confirmed Cases About the Relative Humidity -- 3.4 Comparison Based on Empirical and Theoretic Data -- 4. CONCLUSION -- REFERENCES -- 7 -- Tackling Coronavirus Disease 2019 by Nonpharmaceutical Interventions -- 1. INTRODUCTION -- 2. PART 1: THE ROLE OF NONPHARMACEUTICAL INTERVENTIONS IN THE MANAGEMENT OF COVID-19 PANDEMIC IN THE WORLD POPULATION -- 2.1 Awareness and Knowledge Dissemination -- 2.2 Lockdown -- 2.3 Physical Distancing -- 2.4 Prohibition on Social Gathering -- 2.5 Restricting Mobility -- 2.6 Improved Hygiene Practices: Mask and Sanitizers -- 2.7 Adapting Online Mode of Living: Telemedicine, Online Class, and Work From Home -- 3. PART 2: INTERROGATING THE ROLE OF NONPHARMACEUTICAL INTERVENTIONS IN THE SAFETY OF HEALTH WORKERS -- 3.1 Infection Prevention and Control.
|
| 505 |
8 |
|
|a 3.1.1 Well-resourced dedicated hospital facility -- 3.1.2 Preventing intrahospital infection and transmission of COVID-19 in healthcare workers -- 3.1.3 Strategies to improve respiratory protection -- 3.1.4 Sample handling -- 3.1.5 Use of appropriate disinfectants -- 3.1.6 Food practices -- 3.1.7 Waste management -- 4. CONCLUSION -- REFERENCES -- 8 -- Belief System, Deity, and Pandemics: A Sociological Analysis -- 1. INTRODUCTION -- 2. STUDIES FROM LITERATURE REVIEW -- 2.1 Coalescing Pandemic and Deity: A Religious Discourse -- 2.2 Beliefs Revolving Around COVID-19 Pandemic and Deity -- 3. THEORETICAL ANALYSIS AND DISCUSSION -- 4. CONCLUSION -- REFERENCES -- 9 -- A Critical Study on Violation of a Decent Burial/Cremation Right of a Dead Person During COVID-19: Special Refe ... -- 1. INTRODUCTION -- 2. RESEARCH METHODOLOGY -- 3. RIGHT OF DECENT BURIAL/CREMATION UNDER INDIAN AND INTERNATIONAL LAWS -- 3.1 Indian Constitution -- 3.2 International Law -- 4. GUIDELINES ISSUED BY THE INDIAN GOVERNMENT FOR THE MANAGEMENT OF DEAD BODIES AT THE BURIAL GROUND/CREMATORIUM DURING THE PA ... -- 4.1 Importance of Guidelines Related to the Management of COVID-19 Dead Bodies -- 5. INCIDENTS OF VIOLATION OF DECENT BURIAL/CREMATION RIGHTS OF A DEAD PERSON DURING COVID-19 -- 6. SUGGESTIONS -- 7. CONCLUSION -- REFERENCES -- 10 -- Effects of Information Communication Technology on Da'wah Activities Amidst COVID-19 Pandemic -- 1. INTRODUCTION -- 2. RESEARCH OBJECTIVES -- 3. RESEARCH QUESTIONS -- 4. CONCEPTUAL ANALYSIS -- 4.1 Da'wah -- 4.2 Information Communication Technology -- 4.3 COVID-19 Pandemic -- 5. RESEARCH DESIGN -- 5.1 Study Population -- 5.1.1 Religious affiliations of participants -- 5.2 Data Analysis and Presentation -- 5.3 Response Rate -- 5.3.1 The extent of the usage of ICT for Da'wah activities during COVID-19 pandemic -- 5.3.1.1 Summary of the study.
|
| 505 |
8 |
|
|a 5.3.1.1 Summary of the study -- 5.3.1.2 Findings of study -- 5.3.1.2 Findings of study -- 5.4 Recommendations from the Study -- 5.5 Conclusion -- REFERENCES -- FURTHER READING -- 11 -- The Impact of Compensation Practices on Employees' Engagement and Motivation in Times of COVID-19 -- 1. INTRODUCTION -- 1.1 Research Question -- 1.2 Research Aim and Objectives -- 1.3 Research Hypotheses -- 2. LITERATURE REVIEW -- 2.1 Compensation -- 2.2 The Importance of Engagement and Motivation -- 2.3 Effective Compensation Packages -- 2.4 Motivation and Employee Engagement -- 2.5 Understanding Motivation Through the "Needs Theories" -- 2.5.1 The 1943 Maslow's hierarchy of needs -- 2.5.2 The 1959 Herzberg dual factor theory -- 2.5.3 The 1969 Clayton Alderfer theory -- 2.5.4 The 1985 self-determination theory -- 2.5.5 The 2002 four drive theory -- 2.6 Employee Engagement Definition -- 2.7 Employee Engagement Types -- 2.8 Performance and Engagement Strategies -- 2.9 Summary of the Literature Review -- 3. METHODOLOGY -- 3.1 Selecting the Research Design -- 3.2 Outcomes -- 4. FINDINGS AND ANALYSIS -- 4.1 Findings -- 4.1.1 Answers of the first three managers -- 4.1.2 Answers of the fourth manager -- 4.1.3 Answers of the last manager -- 4.2 Analysis -- 4.2.1 Question 1: How do you motivate your employees? How do you perceive them to be motivated? -- 4.2.2 Question 2: How are they motivated? Are they motivated by internal or external factors? -- 4.2.3 Question 3: What are the compensation packages available at your organization? -- 4.2.4 Question 4: Do you use an incentive profile (security, recognition, rewards, responsibility, and so on) in order to know wh ... -- 4.2.5 Question 5: How do you approach employees concerning motivation, do you approach them differently because of age? -- 4.2.6 Question 6: Which reward system do you believe the employees prefer? Why?.
|
| 650 |
|
0 |
|a Epidemics.
|
| 650 |
|
0 |
|a Epidemics
|x Prevention.
|
| 650 |
|
0 |
|a COVID-19 (Disease)
|
| 650 |
|
0 |
|a COVID-19 Pandemic, 2020-
|
| 650 |
|
2 |
|a COVID-19
|0 (DNLM)D000086382
|
| 650 |
|
6 |
|a COVID-19.
|0 (CaQQLa)000313216
|
| 650 |
|
6 |
|a Pand�emie de COVID-19, 2020-
|0 (CaQQLa)000314058
|
| 650 |
|
7 |
|a COVID-19 (Disease)
|2 fast
|0 (OCoLC)fst01984643
|
| 650 |
|
7 |
|a Epidemics.
|2 fast
|0 (OCoLC)fst00914079
|
| 650 |
|
7 |
|a Epidemics
|x Prevention.
|2 fast
|0 (OCoLC)fst00914085
|
| 647 |
|
7 |
|a COVID-19 Pandemic
|d (2020- )
|2 fast
|0 (OCoLC)fst02024716
|
| 700 |
1 |
|
|a Chatterjee, Saptarshi,
|e editor.
|
| 776 |
0 |
8 |
|i Print version:
|z 0323858449
|z 9780323858441
|w (OCoLC)1230230907
|
| 856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780323858441
|z Texto completo
|
